Mitsuo Sawai
Chief Executive Officer at SAWAI GROUP HOLDINGS CO., LTD.
Net worth: 40 M $ as of 29/04/2024
Mitsuo Sawai active positions
| Companies | Position | Start | End |
|---|---|---|---|
| SAWAI GROUP HOLDINGS CO., LTD. | Chief Executive Officer | 31/03/2021 | - |
| Chairman | 31/03/2021 | - | |
Sawai Pharmaceutical Co., Ltd.
 Sawai Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Sawai Pharmaceutical Co., Ltd. engages in the manufacture and sale of prescription pharmaceutical products. Its products include cardiovascular drugs, antihyperlipidemic agents, diabetes, anticancer drugs, and over-the-counter drugs. It operates through the Japan and United States segments. The Japan segment sells manufactured pharmaceuticals to domestic sales companies, wholesale stores and other pharmaceutical manufacturers, as well as directly to medical institutions. The United States segment comprises of holding companies that manages subsidiaries and sell manufactured pharmaceuticals to wholesale stores in the United States. The company was founded by Hanpei Sawai and Noyo Sawai on April 1, 1929 and is headquartered in Osaka, Japan. | Chairman | 22/06/2020 | - |
| Director/Board Member | 31/05/2000 | 22/06/2020 | |
| President | 31/05/2008 | 22/06/2020 | |
| Sales & Marketing | 31/05/2000 | 31/05/2008 |
Career history of Mitsuo Sawai
Statistics
International
| Japan | 3 |
Operational
| Chairman | 2 |
| Director/Board Member | 1 |
| President | 1 |
Sectoral
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| SAWAI GROUP HOLDINGS CO., LTD. | Health Technology |
| Private companies | 1 |
|---|---|
Sawai Pharmaceutical Co., Ltd.
Sawai Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Sawai Pharmaceutical Co., Ltd. engages in the manufacture and sale of prescription pharmaceutical products. Its products include cardiovascular drugs, antihyperlipidemic agents, diabetes, anticancer drugs, and over-the-counter drugs. It operates through the Japan and United States segments. The Japan segment sells manufactured pharmaceuticals to domestic sales companies, wholesale stores and other pharmaceutical manufacturers, as well as directly to medical institutions. The United States segment comprises of holding companies that manages subsidiaries and sell manufactured pharmaceuticals to wholesale stores in the United States. The company was founded by Hanpei Sawai and Noyo Sawai on April 1, 1929 and is headquartered in Osaka, Japan. | Health Technology |
- Stock Market
- Insiders
- Mitsuo Sawai
- Experience
